Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo

Pediatrics

Volumn 133, Issue 6, 2014, Pages 1023-1030

  Ohls, Robin K ^a   Kamath Rayne, Beena D ^b   Christensen, Robert D ^c   Wiedmeier, Susan E ^d   Rosenberg, Adam ^e   Fuller, Janell ^a   Lacy, Conra Backstrom ^a   Roohi, Mahshid ^a   Lambert, Diane K ^c   Burnett, Jill J ^f   Pruckler, Barbara ^e   Peceny, Hannah ^a   Cannon, Daniel C ^g   Lowe, Jean R ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c INTERMOUNTAIN HEALTHCARE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e University of Colorado Denver and Children s Hospital Colorado   (United States)

^f INTERMOUNTAIN MEDICAL CENTER   (United States)

^g UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cognitive outcome; Darbepoetin; Erythropoietin; Prematurity

Indexed keywords

ALPHA TOCOPHEROL; ERYTHROPOIETIN; FOLIC ACID; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO;

ANTHROPOMETRY; ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; BLOOD TRANSFUSION; BRAIN DISEASE; CEREBRAL PALSY; CLINICAL PROTOCOL; COGNITION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEARING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MULTICENTER STUDY; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; VISION;

COGNITIVE OUTCOME; DARBEPOETIN; ERYTHROPOIETIN; PREMATURITY;

BLOOD TRANSFUSION; COGNITION; CONCEPT FORMATION; DEVELOPMENTAL DISABILITIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INJECTIONS, SUBCUTANEOUS; MALE; MEMORY, SHORT-TERM; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PROSPECTIVE STUDIES;

EID: 84901857282     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-4307     Document Type: Article

References (34)

1. Bishara N, Ohls RK. Current controversies in the management of the anemia of prematurity. Semin Perinatol. 2009;33(1):29-34
2. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer. 2001;84(Suppl 1):3-10 (Pubitemid 32453429)
3. Warwood TL, Ohls RK, Wiedmeier SE, et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol. 2005;25(11):725-730 (Pubitemid 41655648)
4. Warwood TL, Ohls RK, Lambert DK, et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol. 2006;26(5):296-300
5. Zhang L, Chopp M, Zhang RL, et al. Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. PLoS One. 2010;5:e11016
6. Iwai M, Stetler RA, Xing J, et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke. 2010;41(5):1032-1037
7. Juul SE, Beyer RP, Bammler TK, McPherson RJ, Wilkerson J, Farin FM. Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus. Pediatr Res. 2009;65(5):485-492
8. Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol. 2000;59(4):419-425 (Pubitemid 30015971)
9. Vairano M, Dello Russo C, Pozzoli G, et al. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci. 2002;16(4):584-592
10. Bierer R, Peceny MC, Hartenberger CH, Ohls RK. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics. 2006;118(3). Available at: www.pediatrics.org/cgi/content/full/118/3/e635
11. Neubauer AP, Voss W, Wachtendorf M, Jungmann T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol. 2010;67(5):657-666
12. Ohls RK, Christensen RD, Kamath-Rayne BD, et al. A randomized, masked, placebo controlled study of darbepoetin administered to preterm infants. Pediatrics. 2013;132(1):119-127
13. Bayley N. Bayley Scales of Infant and Toddler Development. Third Edition. San Antonio, TX: Harcourt Assessment; 2006
14. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and validation of a gross motor function classification system for children with cerebral palsy. Dev Med Child Neurol. 1997;39:214-223 (Pubitemid 27226331)
15. Lowe J, MacLean PC, Shaffer ML, Watterberg K. Early working memory in children born with extremely low birth weight: assessed by object permanence. J Child Neurol. 2009;24(4):410-415
16. Ohls RK, Ehrenkranz RA, Das A, et al National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics. 2004;114(5):1287-1291 (Pubitemid 41647690)
17. Ohls RK, Ehrenkranz RA, Wright LL, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics. 2001;108(4):934-942 (Pubitemid 32947663)
18. McCoy TE, Conrad AL, Richman LC, Lindgren SD, Nopoulos PC, Bell EF. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol. 2011;17(4):347-367
19. Nopoulos PC, Conrad AL, Bell EF, et al. Long-term outcome of brain structure in premature infants: effects of liberal vs restricted red blood cell transfusions. Arch Pediatr Adolesc Med. 2011;165(5):443-450
20. Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res. 2002;44(4):391-403 (Pubitemid 35341813)
21. Brown MS, Eichorst D, Lala-Black B, Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics. 2009;124(4). Available at: www.pediatrics.org/cgi/content/full/124/4/e681
22. McAdams RM, McPherson RJ, Mayock DE, Juul SE. Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol. 2013;33(3):226-230
23. Woodward LJ, Edgin JO, Thompson D, Inder TE. Object working memory deficits predicted by early brain injury and development in the preterm infant. Brain. 2005;128(Pt 11):2578-2587 (Pubitemid 41552943)
24. Woodward LJ, Clark CA, Pritchard VE, Anderson PJ, Inder TE. Neonatal white matter abnormalities predict global executive function impairment in children born very preterm. Dev Neuropsychol. 2011;36(1):22-41
25. Anderson PJ, Doyle LW. Cognitive and educational deficits in children born extremely preterm. Semin Perinatol. 2008;32(1):51-58 (Pubitemid 351181451)
26. Aarnoudse-Moens CS, Oosterlaan J, Duivenvoorden HJ, van Goudoever JB, Weisglas-Kuperus N. Development of preschool and academic skills in children born very preterm. J Pediatr. 2011;158(1):51-56
27. Fretham SJ, Carlson ES, Georgieff MK. The role of iron in learning and memory. Adv Nutr. 2011;2(2):112-121
28. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301-307
29. Whyte RK, Kirpalani H, Asztalos EV, et al PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009;123(1):207-213
30. Bell EF, Strauss RG, Widness JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. 2005;115(6):1685-1691 (Pubitemid 43843180)
31. Ohls RK, Roohi M, Peceny HM, Schrader R, Bierer R. A randomized, masked study of weekly erythropoietin dosing in preterm infants. J Pediatr. 2012;160(5):790-795, e1
32. Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr. 1997;131(5):661-665 (Pubitemid 27524841)
33. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2014, In press
34. Aher S, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2014, In press